Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2024
Novel avenues of tau researchClaire E Sexton, Gal Bitan, Kathryn R Bowles, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.Nature Genetics|June 21, 2011
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsyGünter U Höglinger, Nadine M Melhem, Dennis W Dickson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U Höglinger, Gesine Respondek, Maria Stamelou, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.Human Genetics|July 1, 2008
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L DeStefano, Jeanne Latourelle, Mark F Lew, et al.Nature Communications|September 9, 2024
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genesKurt Farrell, Jack Humphrey, Timothy Chang, et al.BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.Nature Communications|June 17, 2015
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsyNaomi Kouri, Owen A Ross, Beth Dombroski, et al.Pageof 5